These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 36798128)

  • 21. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCG vaccine: a hope to control COVID-19 pandemic amid crisis.
    Malik YS; Ansari MI; Ganesh B; Sircar S; Bhat S; Pande T; Vinodhkumar OR; Kumar P; Iqbal Yatoo M; Tiwari R; Touil N; Patel SK; Pathak M; Sharun K; Dhama K
    Hum Vaccin Immunother; 2020 Dec; 16(12):2954-2962. PubMed ID: 32991235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice.
    Zhang BZ; Shuai H; Gong HR; Hu JC; Yan B; Yuen TT; Hu YF; Yoon C; Wang XL; Hou Y; Lin X; Huang X; Li R; Au-Yeung YM; Li W; Hu B; Chai Y; Yue M; Cai JP; Ling GS; Hung IF; Yuen KY; Chan JF; Huang JD; Chu H
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35446790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base.
    Nachega JB; Maeurer M; Sam-Agudu NA; Chakaya J; Katoto PDM; Zumla A
    Int J Infect Dis; 2021 Dec; 113 Suppl 1():S78-S81. PubMed ID: 33794380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacille Calmette-Guérin Vaccination in Infancy Does Not Protect Against Coronavirus Disease 2019 (COVID-19): Evidence From a Natural Experiment in Sweden.
    de Chaisemartin C; de Chaisemartin L
    Clin Infect Dis; 2021 May; 72(10):e501-e505. PubMed ID: 32829400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the BCG vaccine a useful tool against COVID-19?
    Zhelezova G; Mateeva V; Mateev G
    Clin Dermatol; 2021; 39(1):98-103. PubMed ID: 33972060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease.
    Velayutham B; Thiruvengadam K; Kumaran PP; Watson B; Rajendran K; Padmapriyadarsini C
    Indian J Med Res; 2023; 157(2&3):152-159. PubMed ID: 36124494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses.
    DiNardo AR; Arditi M; Kamat AM; Koster KJ; Carrero S; Nishiguchi T; Lebedev M; Benjamin AB; Avalos P; Lozano M; Moule MG; McCune B; Herron B; Ladki M; Sheikh D; Spears M; Herrejon IA; Dodge C; Kumar S; Hutchison RW; Ofili TU; Opperman LA; Bernard JA; Lerner SP; Udeani G; Neal G; Netea MG; Cirillo JD
    Trials; 2023 Oct; 24(1):636. PubMed ID: 37794431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
    Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
    J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCG vaccination provides protection against IAV but not SARS-CoV-2.
    Kaufmann E; Khan N; Tran KA; Ulndreaj A; Pernet E; Fontes G; Lupien A; Desmeules P; McIntosh F; Abow A; Moorlag SJCFM; Debisarun P; Mossman K; Banerjee A; Karo-Atar D; Sadeghi M; Mubareka S; Vinh DC; King IL; Robbins CS; Behr MA; Netea MG; Joubert P; Divangahi M
    Cell Rep; 2022 Mar; 38(10):110502. PubMed ID: 35235831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
    Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
    Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
    Gupta PK
    Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research progress in the off-target effects of Bacille Calmette-Guérin vaccine.
    Wu Y; Zhang X; Zhou L; Lu J; Zhu F; Li J
    Chin Med J (Engl); 2024 Sep; 137(17):2065-2074. PubMed ID: 38092722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19.
    Morrison AL; Sharpe S; White AD; Bodman-Smith M
    Front Immunol; 2021; 12():743924. PubMed ID: 34567010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19?
    Finotti P
    Cell Stress Chaperones; 2022 Jan; 27(1):37-43. PubMed ID: 34755305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCG mediated protection of the lung against experimental SARS-CoV-2 infection.
    Hilligan KL; Namasivayam S; Sher A
    Front Immunol; 2023; 14():1232764. PubMed ID: 37744331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.